Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 9

1.

Clinical study of recombinant adenovirus-p53 combined with fractionated stereotactic radiotherapy for hepatocellular carcinoma.

Yang ZX, Wang D, Wang G, Zhang QH, Liu JM, Peng P, Liu XH.

J Cancer Res Clin Oncol. 2010 Apr;136(4):625-30. doi: 10.1007/s00432-009-0701-6. Epub 2009 Oct 31.

PMID:
19882171
2.

Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma.

Wu SX, Chua DT, Deng ML, Zhao C, Li FY, Sham JS, Wang HY, Bao Y, Gao YH, Zeng ZF.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):761-9. Epub 2007 Jul 2. Review.

PMID:
17601682
3.

Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas.

Paek SH, Downes MB, Bednarz G, Keane WM, Werner-Wasik M, Curran WJ Jr, Andrews DW.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):795-808. Review.

PMID:
15708259
4.

Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature.

Milker-Zabel S, Zabel-du Bois A, Huber P, Schlegel W, Debus J.

Strahlenther Onkol. 2006 Nov;182(11):635-40. Review.

PMID:
17072520
5.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
6.

Stereotactic radiation therapy and selective internal radiation therapy for hepatocellular carcinoma.

Bujold A, Dawson LA.

Cancer Radiother. 2011 Feb;15(1):54-63. doi: 10.1016/j.canrad.2010.11.003. Epub 2011 Jan 15. Review.

PMID:
21239204
7.

Stereotactic body radiation therapy: A novel treatment modality for inoperable hepatocellular carcinoma.

Meng M, Wang H, Zeng X, Zhao L, Yuan Z, Wang P, Hao X.

Drug Discov Ther. 2015 Oct;9(5):372-9. doi: 10.5582/ddt.2015.01056. Review.

8.

Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma.

Klein J, Korol R, Lo SS, Chu W, Lock M, Dorth JA, Ellis RJ, Mayr NA, Huang Z, Chung HT.

Future Oncol. 2014 Nov;10(14):2227-41. doi: 10.2217/fon.14.167. Review.

PMID:
25471036
9.

Key points of basic theories and clinical practice in rAd-p53 ( Gendicine ™) gene therapy for solid malignant tumors.

Li Y, Li B, Li CJ, Li LJ.

Expert Opin Biol Ther. 2015 Mar;15(3):437-54. doi: 10.1517/14712598.2015.990882. Epub 2014 Dec 12. Review.

PMID:
25496374
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk